Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 Volcon VLCN 24. avr 2025 0.79 -2.47   
 VolitionRX VNRX 24. avr 2025 0.49 +2.08   
 Vontier VNT 24. avr 2025 31.29 +3.51   
 Vor Biopharma VOR 24. avr 2025 0.73 -4.19   
 Vornado Realty Trust VNO 24. avr 2025 35.49 +1.63   
 Vornado Realty Trust L Pref VNO-L 24. avr 2025 17.48 +2.19   
 Vornado Realty Trust M Pref VNO-M 24. avr 2025 17.01 +2.41   
 Vornado Realty Trust N VNO-N 24. avr 2025 16.90 +1.93   
 Vornado Realty Trust O Pref VNO-O 24. avr 2025 14.45 +0.14   
 Vox Royalty VOXR 24. avr 2025 3.40 +2.10   
 VOXX International A VOXX 24. avr 2025 7.50 0.00   
 Voya Asia Pacific High Dividend Equity Income Fund IAE 24. avr 2025 6.09 +0.36   
 Voya Emerging Markets High Income Dividend Equity Fund IHD 24. avr 2025 5.17 +1.39   
 Voya Financial VOYA 24. avr 2025 59.07 +2.75   
 Voya Financial B Pref VOYA-B 24. avr 2025 23.81 +0.93   
 Voya Global Advantage And Premium Opportunity Fund IGA 24. avr 2025 9.92 +0.71   
 Voya Global Equity Dividend And Premium Opportunity Fund IGD 24. avr 2025 5.52 +0.73   
 Voya Infrastructure Industrials And Materials Fund IDE 24. avr 2025 10.46 +3.05   
 Voyager Acquisition VACH 24. avr 2025 10.25 -0.09   
 Voyager Acquisition VACHU 24. avr 2025 10.24 0.00   
 Voyager Therapeutics VYGR 24. avr 2025 3.53 +1.15   
 Vrdo Tax-Free Weekly Powershares PVI 24. avr 2025 24.88 -0.10   
 VS Media VSME 24. avr 2025 1.03 +18.39   
 VSE VSEC 24. avr 2025 113.70 +5.19   
 VSee Health VSEE 24. avr 2025 1.27 +6.72   
 VTEX A VTEX 24. avr 2025 5.35 +4.29   
 vTv Therapeutics A VTVT 24. avr 2025 22.50 +9.49   
 Vulcan Materials VMC 24. avr 2025 249.51 +2.03   
 Vuzix VUZI 24. avr 2025 1.83 +7.02   
 Vyne Therapeutics VYNE 24. avr 2025 1.88 +2.17   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.